Report Cover

Global and Japan Vitamin K Antagonists (VKA) Market Insights, Forecast to 2027


Vitamin K Antagonists (VKA) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Vitamin K Antagonists (VKA) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Vitamin K Antagonists (VKA) market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
    Oral Vitamin K Antagonists
    Injection Vitamin K Antagonists

Segment by Application
    VTE
    ACS/MI
    AF
    Others

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Sanofi
    Bristol-Myers Squibb
    Bayer
    Johnson & Johnson
    Genentech (Roche)
    Boehringer Ingelheim
    Lilly
    Daiichi Sankyo
    Otsuka
    AstraZeneca
    Pfizer
    Aspen
    The Medicines Company
1 Study Coverage
    1.1 Vitamin K Antagonists (VKA) Product Introduction
    1.2 Market by Type
        1.2.1 Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Type
        1.2.2 Oral Vitamin K Antagonists
        1.2.3 Injection Vitamin K Antagonists
    1.3 Market by Application
        1.3.1 Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Application
        1.3.2 VTE
        1.3.3 ACS/MI
        1.3.4 AF
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Vitamin K Antagonists (VKA) Market Size, Estimates and Forecasts
        2.1.1 Global Vitamin K Antagonists (VKA) Revenue 2016-2027
        2.1.2 Global Vitamin K Antagonists (VKA) Sales 2016-2027
    2.2 Global Vitamin K Antagonists (VKA), Market Size by Region: 2016 VS 2021 VS 2027
    2.3 Vitamin K Antagonists (VKA) Historical Market Size by Region (2016-2021)
        2.3.1 Global Vitamin K Antagonists (VKA) Retrospective Market Scenario in Sales by Region: 2016-2021
        2.3.2 Global Vitamin K Antagonists (VKA) Retrospective Market Scenario in Revenue by Region: 2016-2021
    2.4 Vitamin K Antagonists (VKA) Market Estimates and Projections by Region (2022-2027)
        2.4.1 Global Vitamin K Antagonists (VKA) Sales Forecast by Region (2022-2027)
        2.4.2 Global Vitamin K Antagonists (VKA) Revenue Forecast by Region (2022-2027)

3 Global Vitamin K Antagonists (VKA) Competitor Landscape by Players
    3.1 Global Top Vitamin K Antagonists (VKA) Manufacturers by Sales
        3.1.1 Global Vitamin K Antagonists (VKA) Sales by Manufacturer (2016-2021)
        3.1.2 Global Vitamin K Antagonists (VKA) Sales Market Share by Manufacturer (2016-2021)
    3.2 Global Top Vitamin K Antagonists (VKA) Manufacturers by Revenue
        3.2.1 Key Vitamin K Antagonists (VKA) Manufacturers Covered: Ranking by Revenue
        3.2.2 Global Vitamin K Antagonists (VKA) Revenue by Manufacturers (2016-2021)
        3.2.3 Global Vitamin K Antagonists (VKA) Revenue Share by Manufacturers (2016-2021)
        3.2.4 Global Vitamin K Antagonists (VKA) Market Concentration Ratio (CR5 and HHI) (2016-2021)
        3.2.5 Global Top 10 and Top 5 Companies by Vitamin K Antagonists (VKA) Revenue in 2020
        3.2.6 Global Vitamin K Antagonists (VKA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Vitamin K Antagonists (VKA) Price by Manufacturers
    3.4 Global Vitamin K Antagonists (VKA) Manufacturing Base Distribution, Product Types
        3.4.1 Vitamin K Antagonists (VKA) Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Vitamin K Antagonists (VKA) Product Type
        3.4.3 Date of International Manufacturers Enter into Vitamin K Antagonists (VKA) Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
    4.1 Global Vitamin K Antagonists (VKA) Market Size by Type (2016-2021)
        4.1.1 Global Vitamin K Antagonists (VKA) Sales by Type (2016-2021)
        4.1.2 Global Vitamin K Antagonists (VKA) Revenue by Type (2016-2021)
        4.1.3 Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Type (2016-2021)
    4.2 Global Vitamin K Antagonists (VKA) Market Size Forecast by Type (2022-2027)
        4.2.1 Global Vitamin K Antagonists (VKA) Sales Forecast by Type (2022-2027)
        4.2.2 Global Vitamin K Antagonists (VKA) Revenue Forecast by Type (2022-2027)
        4.2.3 Vitamin K Antagonists (VKA) Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
    5.1 Global Vitamin K Antagonists (VKA) Market Size by Application (2016-2021)
        5.1.1 Global Vitamin K Antagonists (VKA) Sales by Application (2016-2021)
        5.1.2 Global Vitamin K Antagonists (VKA) Revenue by Application (2016-2021)
        5.1.3 Vitamin K Antagonists (VKA) Price by Application (2016-2021)
    5.2 Vitamin K Antagonists (VKA) Market Size Forecast by Application (2022-2027)
        5.2.1 Global Vitamin K Antagonists (VKA) Sales Forecast by Application (2022-2027)
        5.2.2 Global Vitamin K Antagonists (VKA) Revenue Forecast by Application (2022-2027)
        5.2.3 Global Vitamin K Antagonists (VKA) Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
    6.1 Japan Vitamin K Antagonists (VKA) Market Size YoY Growth 2016-2027
        6.1.1 Japan Vitamin K Antagonists (VKA) Sales YoY Growth 2016-2027
        6.1.2 Japan Vitamin K Antagonists (VKA) Revenue YoY Growth 2016-2027
        6.1.3 Japan Vitamin K Antagonists (VKA) Market Share in Global Market 2016-2027
    6.2 Japan Vitamin K Antagonists (VKA) Market Size by Players (International and Local Players)
        6.2.1 Japan Top Vitamin K Antagonists (VKA) Players by Sales (2016-2021)
        6.2.2 Japan Top Vitamin K Antagonists (VKA) Players by Revenue (2016-2021)
    6.3 Japan Vitamin K Antagonists (VKA) Historic Market Review by Type (2016-2021)
        6.3.1 Japan Vitamin K Antagonists (VKA) Sales Market Share by Type (2016-2021)
        6.3.2 Japan Vitamin K Antagonists (VKA) Revenue Market Share by Type (2016-2021)
        6.3.3 Japan Vitamin K Antagonists (VKA) Price by Type (2016-2021)
    6.4 Japan Vitamin K Antagonists (VKA) Market Estimates and Forecasts by Type (2022-2027)
        6.4.1 Japan Vitamin K Antagonists (VKA) Sales Forecast by Type (2022-2027)
        6.4.2 Japan Vitamin K Antagonists (VKA) Revenue Forecast by Type (2022-2027)
        6.4.3 Japan Vitamin K Antagonists (VKA) Price Forecast by Type (2022-2027)
    6.5 Japan Vitamin K Antagonists (VKA) Historic Market Review by Application (2016-2021)
        6.5.1 Japan Vitamin K Antagonists (VKA) Sales Market Share by Application (2016-2021)
        6.5.2 Japan Vitamin K Antagonists (VKA) Revenue Market Share by Application (2016-2021)
        6.5.3 Japan Vitamin K Antagonists (VKA) Price by Application (2016-2021)
    6.6 Japan Vitamin K Antagonists (VKA) Market Estimates and Forecasts by Application (2022-2027)
        6.6.1 Japan Vitamin K Antagonists (VKA) Sales Forecast by Application (2022-2027)
        6.6.2 Japan Vitamin K Antagonists (VKA) Revenue Forecast by Application (2022-2027)
        6.6.3 Japan Vitamin K Antagonists (VKA) Price Forecast by Application (2022-2027)

7 North America
    7.1 North America Vitamin K Antagonists (VKA) Market Size YoY Growth 2016-2027
    7.2 North America Vitamin K Antagonists (VKA) Market Facts & Figures by Country
        7.2.1 North America Vitamin K Antagonists (VKA) Sales by Country (2016-2021)
        7.2.2 North America Vitamin K Antagonists (VKA) Revenue by Country (2016-2021)
        7.2.3 U.S.
        7.2.4 Canada

8 Asia Pacific
    8.1 Asia Pacific Vitamin K Antagonists (VKA) Market Size YoY Growth 2016-2027
    8.2 Asia Pacific Vitamin K Antagonists (VKA) Market Facts & Figures by Region
        8.2.1 Asia Pacific Vitamin K Antagonists (VKA) Sales by Region (2016-2021)
        8.2.2 Asia Pacific Vitamin K Antagonists (VKA) Revenue by Region (2016-2021)
        8.2.3 China
        8.2.4 Japan
        8.2.5 South Korea
        8.2.6 India
        8.2.7 Australia
        8.2.8 Australia
        8.2.9 Indonesia
        8.2.10 Thailand
        8.2.11 Malaysia
        8.2.12 Philippines
        8.2.13 Vietnam

9 Europe
    9.1 Europe Vitamin K Antagonists (VKA) Market Size YoY Growth 2016-2027
    9.2 Europe Vitamin K Antagonists (VKA) Market Facts & Figures by Country
        9.2.1 Europe Vitamin K Antagonists (VKA) Sales by Country (2016-2021)
        9.2.2 Europe Vitamin K Antagonists (VKA) Revenue by Country (2016-2021)
        9.2.3 Germany
        9.2.4 France
        9.2.5 U.K.
        9.2.6 Italy

10 Latin America
    10.1 Latin America Vitamin K Antagonists (VKA) Market Size YoY Growth 2016-2027
    10.2 Latin America Vitamin K Antagonists (VKA) Market Facts & Figures by Country
        10.2.1 Latin America Vitamin K Antagonists (VKA) Sales by Country (2016-2021)
        10.2.2 Latin America Vitamin K Antagonists (VKA) Revenue by Country (2016-2021)
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Vitamin K Antagonists (VKA) Market Size YoY Growth 2016-2027
    11.2 Middle East and Africa Vitamin K Antagonists (VKA) Market Facts & Figures by Country
        11.2.1 Middle East and Africa Vitamin K Antagonists (VKA) Sales by Country (2016-2021)
        11.2.2 Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Country (2016-2021)
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 UAE

12 Company Profiles
    12.1 Sanofi
        12.1.1 Sanofi Corporation Information
        12.1.2 Sanofi Description and Business Overview
        12.1.3 Sanofi Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Sanofi Vitamin K Antagonists (VKA) Products Offered
        12.1.5 Sanofi Recent Development
    12.2 Bristol-Myers Squibb
        12.2.1 Bristol-Myers Squibb Corporation Information
        12.2.2 Bristol-Myers Squibb Description and Business Overview
        12.2.3 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Products Offered
        12.2.5 Bristol-Myers Squibb Recent Development
    12.3 Bayer
        12.3.1 Bayer Corporation Information
        12.3.2 Bayer Description and Business Overview
        12.3.3 Bayer Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Bayer Vitamin K Antagonists (VKA) Products Offered
        12.3.5 Bayer Recent Development
    12.4 Johnson & Johnson
        12.4.1 Johnson & Johnson Corporation Information
        12.4.2 Johnson & Johnson Description and Business Overview
        12.4.3 Johnson & Johnson Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Johnson & Johnson Vitamin K Antagonists (VKA) Products Offered
        12.4.5 Johnson & Johnson Recent Development
    12.5 Genentech (Roche)
        12.5.1 Genentech (Roche) Corporation Information
        12.5.2 Genentech (Roche) Description and Business Overview
        12.5.3 Genentech (Roche) Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Genentech (Roche) Vitamin K Antagonists (VKA) Products Offered
        12.5.5 Genentech (Roche) Recent Development
    12.6 Boehringer Ingelheim
        12.6.1 Boehringer Ingelheim Corporation Information
        12.6.2 Boehringer Ingelheim Description and Business Overview
        12.6.3 Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Boehringer Ingelheim Vitamin K Antagonists (VKA) Products Offered
        12.6.5 Boehringer Ingelheim Recent Development
    12.7 Lilly
        12.7.1 Lilly Corporation Information
        12.7.2 Lilly Description and Business Overview
        12.7.3 Lilly Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Lilly Vitamin K Antagonists (VKA) Products Offered
        12.7.5 Lilly Recent Development
    12.8 Daiichi Sankyo
        12.8.1 Daiichi Sankyo Corporation Information
        12.8.2 Daiichi Sankyo Description and Business Overview
        12.8.3 Daiichi Sankyo Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Daiichi Sankyo Vitamin K Antagonists (VKA) Products Offered
        12.8.5 Daiichi Sankyo Recent Development
    12.9 Otsuka
        12.9.1 Otsuka Corporation Information
        12.9.2 Otsuka Description and Business Overview
        12.9.3 Otsuka Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Otsuka Vitamin K Antagonists (VKA) Products Offered
        12.9.5 Otsuka Recent Development
    12.10 AstraZeneca
        12.10.1 AstraZeneca Corporation Information
        12.10.2 AstraZeneca Description and Business Overview
        12.10.3 AstraZeneca Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 AstraZeneca Vitamin K Antagonists (VKA) Products Offered
        12.10.5 AstraZeneca Recent Development
    12.11 Sanofi
        12.11.1 Sanofi Corporation Information
        12.11.2 Sanofi Description and Business Overview
        12.11.3 Sanofi Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Sanofi Vitamin K Antagonists (VKA) Products Offered
        12.11.5 Sanofi Recent Development
    12.12 Aspen
        12.12.1 Aspen Corporation Information
        12.12.2 Aspen Description and Business Overview
        12.12.3 Aspen Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 Aspen Products Offered
        12.12.5 Aspen Recent Development
    12.13 The Medicines Company
        12.13.1 The Medicines Company Corporation Information
        12.13.2 The Medicines Company Description and Business Overview
        12.13.3 The Medicines Company Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2016-2021)
        12.13.4 The Medicines Company Products Offered
        12.13.5 The Medicines Company Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Vitamin K Antagonists (VKA) Industry Trends
    13.2 Vitamin K Antagonists (VKA) Market Drivers
    13.3 Vitamin K Antagonists (VKA) Market Challenges
    13.4 Vitamin K Antagonists (VKA) Market Restraints

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Vitamin K Antagonists (VKA) Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables Table 1. Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Oral Vitamin K Antagonists Table 3. Major Manufacturers of Injection Vitamin K Antagonists Table 4. Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Application (2021-2027) & (K MT) Table 5. Global Vitamin K Antagonists (VKA) Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global Vitamin K Antagonists (VKA) Sales by Regions (2016-2021) & (K MT) Table 7. Global Vitamin K Antagonists (VKA) Sales Market Share by Regions (2016-2021) Table 8. Global Vitamin K Antagonists (VKA) Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global Vitamin K Antagonists (VKA) Sales Forecast by Region (2022-2027) & (K MT) Table 10. Global Vitamin K Antagonists (VKA) Sales Market Share Forecast by Region (2022-2027) Table 11. Global Vitamin K Antagonists (VKA) Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global Vitamin K Antagonists (VKA) Revenue Market Share Forecast by Region (2022-2027) Table 13. Global Vitamin K Antagonists (VKA) Sales by Manufacturers (2016-2021) (K MT) Table 14. Global Vitamin K Antagonists (VKA) Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top Vitamin K Antagonists (VKA) Manufacturers by Revenue (US$ Million) in 2020 Table 16. Vitamin K Antagonists (VKA) Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. Vitamin K Antagonists (VKA) Revenue Share by Manufacturers (2016-2021) Table 18. Global Vitamin K Antagonists (VKA) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global Vitamin K Antagonists (VKA) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vitamin K Antagonists (VKA) as of 2020) Table 20. Key Manufacturers Vitamin K Antagonists (VKA) Price (2016-2021) (USD/MT) Table 21. Vitamin K Antagonists (VKA) Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Vitamin K Antagonists (VKA) Product Type Table 23. Date of International Manufacturers Enter into Vitamin K Antagonists (VKA) Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Vitamin K Antagonists (VKA) Sales by Type (2016-2021) (K MT) Table 26. Global Vitamin K Antagonists (VKA) Sales Share by Type (2016-2021) Table 27. Global Vitamin K Antagonists (VKA) Revenue by Type (2016-2021) (US$ Million) Table 28. Global Vitamin K Antagonists (VKA) Revenue Share by Type (2016-2021) Table 29. Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Type (2016-2021) & (USD/MT) Table 30. Global Vitamin K Antagonists (VKA) Sales Forecast by Type (2022-2027) & (K MT) Table 31. Global Vitamin K Antagonists (VKA) Sales Market Share Forecast by Type (2022-2027) Table 32. Global Vitamin K Antagonists (VKA) Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global Vitamin K Antagonists (VKA) Revenue Market Share Forecast by Type (2022-2027) Table 34. Global Vitamin K Antagonists (VKA) Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT) Table 35. Global Vitamin K Antagonists (VKA) Sales by Application (2016-2021) (K MT) Table 36. Global Vitamin K Antagonists (VKA) Sales Share by Application (2016-2021) Table 37. Global Vitamin K Antagonists (VKA) Revenue by Application (2016-2021) (US$ Million) Table 38. Global Vitamin K Antagonists (VKA) Revenue Share by Application (2016-2021) Table 39. Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Application (2016-2021) & (USD/MT) Table 40. Global Vitamin K Antagonists (VKA) Sales Forecast by Application (2022-2027) & (K MT) Table 41. Global Vitamin K Antagonists (VKA) Sales Market Share Forecast by Application (2022-2027) Table 42. Global Vitamin K Antagonists (VKA) Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global Vitamin K Antagonists (VKA) Revenue Market Share Forecast by Application (2022-2027) Table 44. Global Vitamin K Antagonists (VKA) Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT) Table 45. Japan Vitamin K Antagonists (VKA) Sales (K MT) of Key Companies (2016-2021) Table 46. Japan Vitamin K Antagonists (VKA) Sales Share by Company (2016-2021) Table 47. Japan Vitamin K Antagonists (VKA) Revenue (US$ Million) by Company (2016-2021) Table 48. Japan Vitamin K Antagonists (VKA) Revenue Share by Company (2016-2021) Table 49. Japan Vitamin K Antagonists (VKA) Sales (K MT) by Type (2016-2021) Table 50. Japan Vitamin K Antagonists (VKA) Sales Share by Type (2016-2021) Table 51. Japan Vitamin K Antagonists (VKA) Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. Japan Vitamin K Antagonists (VKA) Price (USD/MT) by Type (2016-2021) Table 53. Japan Vitamin K Antagonists (VKA) Sales (K MT) by Type (2022-2027) Table 54. Japan Vitamin K Antagonists (VKA) Sales Share by Type (2022-2027) Table 55. Japan Vitamin K Antagonists (VKA) Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. Japan Vitamin K Antagonists (VKA) Revenue Share by Type (2022-2027) Table 57. Japan Vitamin K Antagonists (VKA) Price (USD/MT) by Type (2022-2027) Table 58. Japan Vitamin K Antagonists (VKA) Sales (K MT) by Application (2016-2021) Table 59. Japan Vitamin K Antagonists (VKA) Sales Share by Application (2016-2021) Table 60. Japan Vitamin K Antagonists (VKA) Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. Japan Vitamin K Antagonists (VKA) Price (USD/MT) by Application (2016-2021) Table 62. Japan Vitamin K Antagonists (VKA) Sales (K MT) by Application (2022-2027) Table 63. Japan Vitamin K Antagonists (VKA) Sales Share by Application (2022-2027) Table 64. Japan Vitamin K Antagonists (VKA) Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. Japan Vitamin K Antagonists (VKA) Revenue Share by Application (2022-2027) Table 66. Japan Vitamin K Antagonists (VKA) Price (USD/MT) by Application (2022-2027) Table 67. North America Vitamin K Antagonists (VKA) Sales by Country (2016-2021) & (K MT) Table 68. North America Vitamin K Antagonists (VKA) Sales Market Share by Country (2016-2021) Table 69. North America Vitamin K Antagonists (VKA) Revenue by Country (2016-2021) & (US$ Million) Table 70. North America Vitamin K Antagonists (VKA) Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific Vitamin K Antagonists (VKA) Sales by Region (2016-2021) & (K MT) Table 72. Asia Pacific Vitamin K Antagonists (VKA) Sales Market Share by Region (2016-2021) Table 73. Asia Pacific Vitamin K Antagonists (VKA) Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific Vitamin K Antagonists (VKA) Revenue Market Share by Region (2016-2021) Table 75. Europe Vitamin K Antagonists (VKA) Sales by Country (2016-2021) & (K MT) Table 76. Europe Vitamin K Antagonists (VKA) Sales Market Share by Country (2016-2021) Table 77. Europe Vitamin K Antagonists (VKA) Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe Vitamin K Antagonists (VKA) Revenue Market Share by Country (2016-2021) Table 79. Latin America Vitamin K Antagonists (VKA) Sales by Country (2016-2021) & (K MT) Table 80. Latin America Vitamin K Antagonists (VKA) Sales Market Share by Country (2016-2021) Table 81. Latin Americaa Vitamin K Antagonists (VKA) Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America Vitamin K Antagonists (VKA) Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa Vitamin K Antagonists (VKA) Sales by Country (2016-2021) & (K MT) Table 84. Middle East and Africa Vitamin K Antagonists (VKA) Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa Vitamin K Antagonists (VKA) Revenue Market Share by Country (2016-2021) Table 87. Sanofi Corporation Information Table 88. Sanofi Description and Business Overview Table 89. Sanofi Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 90. Sanofi Vitamin K Antagonists (VKA) Product Table 91. Sanofi Recent Development Table 92. Bristol-Myers Squibb Corporation Information Table 93. Bristol-Myers Squibb Description and Business Overview Table 94. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 95. Bristol-Myers Squibb Product Table 96. Bristol-Myers Squibb Recent Development Table 97. Bayer Corporation Information Table 98. Bayer Description and Business Overview Table 99. Bayer Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 100. Bayer Product Table 101. Bayer Recent Development Table 102. Johnson & Johnson Corporation Information Table 103. Johnson & Johnson Description and Business Overview Table 104. Johnson & Johnson Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 105. Johnson & Johnson Product Table 106. Johnson & Johnson Recent Development Table 107. Genentech (Roche) Corporation Information Table 108. Genentech (Roche) Description and Business Overview Table 109. Genentech (Roche) Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 110. Genentech (Roche) Product Table 111. Genentech (Roche) Recent Development Table 112. Boehringer Ingelheim Corporation Information Table 113. Boehringer Ingelheim Description and Business Overview Table 114. Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 115. Boehringer Ingelheim Product Table 116. Boehringer Ingelheim Recent Development Table 117. Lilly Corporation Information Table 118. Lilly Description and Business Overview Table 119. Lilly Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 120. Lilly Product Table 121. Lilly Recent Development Table 122. Daiichi Sankyo Corporation Information Table 123. Daiichi Sankyo Description and Business Overview Table 124. Daiichi Sankyo Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 125. Daiichi Sankyo Product Table 126. Daiichi Sankyo Recent Development Table 127. Otsuka Corporation Information Table 128. Otsuka Description and Business Overview Table 129. Otsuka Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 130. Otsuka Product Table 131. Otsuka Recent Development Table 132. AstraZeneca Corporation Information Table 133. AstraZeneca Description and Business Overview Table 134. AstraZeneca Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 135. AstraZeneca Product Table 136. AstraZeneca Recent Development Table 137. Pfizer Corporation Information Table 138. Pfizer Description and Business Overview Table 139. Pfizer Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 140. Pfizer Product Table 141. Pfizer Recent Development Table 142. Aspen Corporation Information Table 143. Aspen Description and Business Overview Table 144. Aspen Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 145. Aspen Product Table 146. Aspen Recent Development Table 147. The Medicines Company Corporation Information Table 148. The Medicines Company Description and Business Overview Table 149. The Medicines Company Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 150. The Medicines Company Product Table 151. The Medicines Company Recent Development Table 152. Vitamin K Antagonists (VKA) Market Trends Table 153. Vitamin K Antagonists (VKA) Market Drivers Table 154. Vitamin K Antagonists (VKA) Market Challenges Table 155. Vitamin K Antagonists (VKA) Market Restraints Table 156. Vitamin K Antagonists (VKA) Customers List Table 157. Vitamin K Antagonists (VKA) Distributors List Table 158. Research Programs/Design for This Report Table 159. Key Data Information from Secondary Sources Table 160. Key Data Information from Primary Sources List of Figures Figure 1. Vitamin K Antagonists (VKA) Product Picture Figure 2. Global Vitamin K Antagonists (VKA) Sales Market Share by Type in 2020 & 2027 Figure 3. Oral Vitamin K Antagonists Product Picture Figure 4. Injection Vitamin K Antagonists Product Picture Figure 5. Global Vitamin K Antagonists (VKA) Sales Market Share by Application in 2020 & 2027 Figure 6. VTE Figure 7. ACS/MI Figure 8. AF Figure 9. Others Figure 10. Vitamin K Antagonists (VKA) Report Years Considered Figure 11. Global Vitamin K Antagonists (VKA) Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Vitamin K Antagonists (VKA) Market Size 2016-2027 (US$ Million) Figure 13. Global Vitamin K Antagonists (VKA) Sales 2016-2027 (K MT) Figure 14. Global Vitamin K Antagonists (VKA) Market Size Market Share by Region: 2021 Versus 2027 Figure 15. Global Vitamin K Antagonists (VKA) Sales Market Share by Region (2016-2021) Figure 16. Global Vitamin K Antagonists (VKA) Sales Market Share by Region in 2020 Figure 17. Global Vitamin K Antagonists (VKA) Revenue Market Share by Region (2016-2021) Figure 18. Global Vitamin K Antagonists (VKA) Revenue Market Share by Region in 2020 Figure 19. Global Vitamin K Antagonists (VKA) Sales Share by Manufacturer in 2020 Figure 20. The Top 10 and 5 Players Market Share by Vitamin K Antagonists (VKA) Revenue in 2020 Figure 21. Vitamin K Antagonists (VKA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 22. Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2016-2021) Figure 23. Global Vitamin K Antagonists (VKA) Sales Market Share by Type in 2020 Figure 24. Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2016-2021) Figure 25. Global Vitamin K Antagonists (VKA) Revenue Market Share by Type in 2020 Figure 26. Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2016-2021) Figure 27. Global Vitamin K Antagonists (VKA) Sales Market Share by Application in 2020 Figure 28. Global Vitamin K Antagonists (VKA) Revenue Market Share by Application (2016-2021) Figure 29. Global Vitamin K Antagonists (VKA) Revenue Market Share by Application in 2020 Figure 30. Japan Vitamin K Antagonists (VKA) Sales Growth Rate 2016-2027 (K MT) Figure 31. Japan Vitamin K Antagonists (VKA) Revenue Growth Rate 2016-2027 (US$ Million) Figure 32. Japan Vitamin K Antagonists (VKA) Market Share in Global Market 2016-2027 Figure 33. Japan 5 and 10 Largest Vitamin K Antagonists (VKA) Players Market Share by Revenue in Vitamin K Antagonists (VKA) in 2020 Figure 34. Japan Vitamin K Antagonists (VKA) Revenue Share by Type (2016-2021) Figure 35. Japan Vitamin K Antagonists (VKA) Revenue Growth Rate by Type in 2016 & 2020 Figure 36. Japan Vitamin K Antagonists (VKA) Revenue Share by Application (2016-2021) Figure 37. Japan Vitamin K Antagonists (VKA) Revenue Growth Rate by Application in 2016 & 2020 Figure 38. North America Vitamin K Antagonists (VKA) Sales Growth Rate 2016-2021 (K MT) Figure 39. North America Vitamin K Antagonists (VKA) Revenue Growth Rate 2016-2021 (US$ Million) Figure 40. North America Vitamin K Antagonists (VKA) Sales Market Share by Country in 2020 Figure 41. North America Vitamin K Antagonists (VKA) Revenue Market Share by Country in 2020 Figure 42. U.S. Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 43. U.S. Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Canada Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 45. Canada Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Europe Vitamin K Antagonists (VKA) Sales Growth Rate 2016-2021 (K MT) Figure 47. Europe Vitamin K Antagonists (VKA) Revenue Growth Rate 2016-2021 (US$ Million) Figure 48. Europe Vitamin K Antagonists (VKA) Sales Market Share by Country in 2020 Figure 49. Europe Vitamin K Antagonists (VKA) Revenue Market Share by Country in 2020 Figure 50. Germany Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 51. Germany Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. France Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 53. France Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. U.K. Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 55. U.K. Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. Italy Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 57. Italy Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Russia Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 59. Russia Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 60. Asia Pacific Vitamin K Antagonists (VKA) Sales Growth Rate 2016-2021 (K MT) Figure 61. Asia Pacific Vitamin K Antagonists (VKA) Revenue Growth Rate 2016-2021 (US$ Million) Figure 62. Asia Pacific Vitamin K Antagonists (VKA) Sales Market Share by Region in 2020 Figure 63. Asia Pacific Vitamin K Antagonists (VKA) Revenue Market Share by Region in 2020 Figure 64. China Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 65. China Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 66. Japan Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 67. Japan Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. South Korea Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 69. South Korea Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. India Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 71. India Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. Australia Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 73. Australia Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Taiwan Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 75. Taiwan Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Indonesia Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 77. Indonesia Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Thailand Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 79. Thailand Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Malaysia Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 81. Malaysia Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Philippines Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 83. Philippines Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Vietnam Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 85. Vietnam Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 86. Latin America Vitamin K Antagonists (VKA) Sales Growth Rate 2016-2021 (K MT) Figure 87. Latin America Vitamin K Antagonists (VKA) Revenue Growth Rate 2016-2021 (US$ Million) Figure 88. Latin America Vitamin K Antagonists (VKA) Sales Market Share by Country in 2020 Figure 89. Latin America Vitamin K Antagonists (VKA) Revenue Market Share by Country in 2020 Figure 90. Mexico Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 91. Mexico Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 92. Brazil Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 93. Brazil Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 94. Argentina Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 95. Argentina Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 96. Middle East and Africa Vitamin K Antagonists (VKA) Sales Growth Rate 2016-2021 (K MT) Figure 97. Middle East and Africa Vitamin K Antagonists (VKA) Revenue Growth Rate 2016-2021 (US$ Million) Figure 98. Middle East and Africa Vitamin K Antagonists (VKA) Sales Market Share by Country in 2020 Figure 99. Middle East and Africa Vitamin K Antagonists (VKA) Revenue Market Share by Country in 2020 Figure 100. Turkey Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 101. Turkey Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 102. Saudi Arabia Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 103. Saudi Arabia Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 104. UAE Vitamin K Antagonists (VKA) Sales Growth Rate (2016-2021) (K MT) Figure 105. UAE Vitamin K Antagonists (VKA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 106. Vitamin K Antagonists (VKA) Value Chain Figure 107. Channels of Distribution Figure 108. Distributors Profiles Figure 109. Bottom-up and Top-down Approaches for This Report Figure 110. Data Triangulation Figure 111. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us